Analyst Ratings for Insight Molecular Diagnostics Inc. (IMDX)
IMDX Rating Summary
IMDX Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.67 (+142.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$9.67 (+142.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/24/2026 | Lucid Capital Markets | Alex Nowak | New Coverage | Buy (N/A) |
8.00 (N/A) |
4.34 (3.98) |
-8.29% | Details |
